Cited by 20Substance Abuse Treatment and OutcomesOpioid Use Disorder TreatmentBehavioral and Psychological Studies

Randomized clinical trial examining duration of voucher-based reinforcement therapy for cocaine abstinence

Open access
Kirby, Kimberly C., Carpenedo, Carolyn M., Dugosh, Karen L., Rosenwasser, Beth J., Benishek, Lois A., Janik, Alicia, Keashen, Rachel, Bresani, Elena +1 more·2013·Drug and Alcohol Dependence

Abstract

Background This is the first study to systematically manipulate duration of voucher-based reinforcement therapy (VBRT) to see if extending the duration increases abstinence during and following VBRT. Methods We randomized cocaine-dependent methadone-maintained adults to Standard (12 weeks; n=62) or Extended (36 weeks; n=68) VBRT and provided escalating voucher amounts contingent upon urinalysis verification of cocaine abstinence. Urinalysis was scheduled at least every 2 weeks during the 48-week study and more frequently during VBRT (3/week) and 12 weeks of Aftercare (2/week). Results Extended VBRT produced longer durations of continuous cocaine abstinence during weeks 1-24 (5.7 vs 2.7 weeks; p=0.003) and proportionally more abstinence during weeks 24-36 (X(2)=4.57, p=.03, OR=2.18) compared to Standard VBRT. Duration of VBRT did not directly predict after-VBRT abstinence; but longer continuous abstinence during VBRT predicted abstinence during Aftercare (p=0.001) and during the last 12 weeks of the study (p<0.001). Extended VBRT averaged higher monthly voucher costs compared to Standard VBRT ($96 vs $43, p<.001); however, the average cost per week of abstinence attained was higher in the Standard group ($8.06 vs $5.88, p<.001). Participants in the Extended group with voucher costs exceeding $25 monthly averaged 20 weeks of continuous abstinence. Conclusions Greater abstinence occurred during Extended VBRT, but providing a longer duration was not by itself sufficient to maintain abstinence after VBRT. However, if abstinence can be captured and sustained during VBRT, then providing longer durations may help increase the continuous abstinence that predicts better long-term outcomes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.drugalcdep.2013.04.015

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Longer-duration contingency management interventions (e.g., six months or longer) are associated with better outcomes.

    “Longer- duration interventions (e.g., six months or longer) are associated with better outcomes 242”

    From Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention (2023) · cites this paper as [242]

    The Results (section 3.3; page unavailable) compare 36 weeks of voucher-based reinforcement therapy with 12 weeks and report better cocaine-abstinence outcomes during treatment. But section 3.4 reports no significant difference in abstinence after treatment ended, so the unqualified claim of better outcomes overstates the finding. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 22

  1. Ayllon T Azrin NH Reinforcer sampling: A technique for increasing the behavior of mental patients J. Appl. Behav. Anal 1968 1 13 20 16795156 PMC1310971
  2. Benishek LA Kirby KC Dugosh KL Padavano A Beliefs about the empirical support of drug abuse treatment interventions: A survey of outpatient treatment providers Drug Alcohol Depend 2010 107 202 208 19959299
  3. Carpenedo CM Kirby CM Dugosh KL Rosenwasser BJ Thompson DL Extended voucher-based reinforcement therapy for long-term drug abstinence Am. J. Health Behav 2010 34 776 787 20604701 PMC3085862
  4. Dallery J Silverman K Chutuape, M A Bigelow GE Stitzer ML Vocher-based reinforcement of opiate plus cocaine abstinence in treatment-resistant methadone patients: Effects of reinforcer magnitude Exp. Clin. Psychopharmacol 2001 9 317 325 11534542
  5. Diggle P Heagerty P Liang KY Zeger S Analysis of Longitudinal Data (2nd edition) Oxford Statistical Science Series #25 2002 New York Oxford University Press, Inc
  6. Griffith JD Rowan-Szal GA Roark RR Simpson DD Contingency management in outpatient methadone treatment: A meta-analysis Drug Alcohol Depend 2000 58 55 66 10669055
  7. Higgins ST Some potential contributions of reinforcement and consumer-demand theory to reducing cocaine use Addict. Behav 1996 21 803 816 8904945
  8. Higgins ST Budney AJ Bickel WK Foerg FE Donham R Badger GJ Incentives improve outcome in outpatient behavioral treatment of cocaine dependence Arch. Gen. Psychiatry 1994 51 568 576 8031230
  9. Higgins ST Wong CJ Badger GJ Ogden DEH Dantona RL Contingent reinforcement increases cocaine abstinence during outpatient treatment and 1 year of follow-up J. Consult. Clin. Psychol 2000 68 64 72 10710841
  10. Kirby KC Benishek LA Dugosh KL Kerwin ME Substance abuse treatment providers' beliefs and objections regarding contingency management: Implications for dissemination Drug Alcohol Depend 2006 85 19 27 16650657
  11. Lussier JP Heil SH Mongeon JA Badger GJ Higgins ST A meta-analysis of voucher-based reinforcement therapy for substance use disorders Addiction 2006 101 192 203 16445548
  12. Madden GJ Bickel WK Jacobs EA Discounting of delayed rewards in opioid-dependent outpatients: exponential or hyperbolic discounting functions? Exp. Clin. Psychopharmacol 1999 7 284 293 10472517
  13. McGovern MP Fox TS Xie H Drake RE A survey of clinical practices and readiness to adopt evidence-based practices: Dissemination research in an addiction treatment system J. Subst. Abuse 2004 26 305 312 15182895
  14. Preston KL Umbricht A Wong CJ Epstein DH Shaping cocaine abstinence by successive approximation J. Consult. Clin. Psychol 2001 69 643 654 11550730
  15. Rachlin H Green L Commitment, choice and self-control J. Exp. Anal. Behav 1972 17 15-15-22 PMC1333886 16811561
  16. Reynolds B A review of delay-discounting research with humans: Relations to drug use and gambling Behav. Pharmacol 2006 17 651 667 17110792
  17. Silverman K Chutuape MA Bigelow GF Stitzer ML Voucher-based reinforcement of cocaine abstinence in treatment-resistant methadone patients: Effects of reinforcement magnitude Psychopharmacology 1999 146 128 138 10525747
  18. Silverman K Robles E Mudric T Bigelow GE Stitzer ML A randomized trial of long-term reinforcement of cocaine abstinence in methadone-maintained patients who inject drugs J. Consult. Clin. Psychol 2004 72 839 854 15482042
  19. Silverman K Wong CJ Higgins ST Brooner RK Montoya ID Contoreggi C Umbricht-Schneiter A Schuster CR Preston KL Increasing opiate abstinence through voucher-based reinforcement therapy Drug Alcohol Depend 1996 41 157 165 8809505
  20. Skinner BF The Behavior of Organisms: An Experimental Analysis 1938 Oxford, England Appleton-Century
  21. Stitzer ML Iguchi MY Felch LJ Contingent take-home incentive: Effects on drug use of methadone maintenance patients J. Consult. Clin. Psychol 1992 60 927 934 1460154
  22. Stitzer ML Peirce J Petry NM Kirby K Roll J Krasnansky J Li R Abstinence-based incentives in methadone maintenance: Interaction with intake stimulant test results Exp. Clin. Psychopharmacol 2007 15 344 359 17696681

Cited by

Sorted by citations

Authors
Kirby, K. C., Carpenedo, C. M., Dugosh, K. L., Rosenwasser, B. J., Benishek, L. A., Janik, A., Keashen, R., Bresani, E., & Silverman, K.
Affiliations
  • Treatment Research Institute (US)
  • Johns Hopkins University (US)
Corresponding author
Kirby, Kimberly C.
Venue
Drug and Alcohol Dependence
Publisher
Elsevier BV
Published
2013-10
Volume
132
Issue
3
Pages
639-645
ISSN
0376-8716 (ISSN-L)
OpenAlex
W2038812789
Cited by
20
References
3
Citations by year
2026: 1 · 2023: 3 · 2022: 3 · 2021: 5 · 2019: 1 · 2017: 2 · 2016: 2 · 2015: 2 · 2014: 1
FWCI
1.21
Type
journal article
Language
en
Open access
Locations
  • Drug and Alcohol Dependence (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Rowan Digitals Works (Rowan University) (submittedVersion)
Funders
National Institute on Drug Abuse (P50DA027841, R01DA017444)
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
Keywords
cocaine dependence, cocaine abstinence, treatment duration, methadone maintenance treatment, follow-up care, relapse prevention, treatment costs, contingency management
MeSH terms
Adult, Female, Follow-Up Studies, Humans, Male, Middle Aged, Reinforcement, Psychology, Temperance, Time Factors, Token Economy, Substance Abuse Treatment Centers, Cocaine-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review